0001225208-14-003602.txt : 20140206 0001225208-14-003602.hdr.sgml : 20140206 20140206203824 ACCESSION NUMBER: 0001225208-14-003602 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140204 FILED AS OF DATE: 20140206 DATE AS OF CHANGE: 20140206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeFord John A CENTRAL INDEX KEY: 0001403373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 14581610 MAIL ADDRESS: STREET 1: C R BARD INC STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2014-02-04 0000009892 BARD C R INC /NJ/ BCR 0001403373 DeFord John A C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Sr. VP Sci Tech and Clin Afrs Common Stock 2014-02-04 4 M 0 11252.0000 84.5750 A 44795.2361 D Common Stock 2014-02-04 4 M 0 10364.0000 86.1450 A 55159.2361 D Common Stock 2014-02-04 4 S 0 538.0000 128.0276 D 54621.2361 D Common Stock 2014-02-04 4 S 0 21078.0000 127.5091 D 33543.2361 D Common Stock 14.4390 I 401(k) Plan Option (Right to Buy) 86.1450 2014-02-04 4 M 0 10364.0000 0.0000 D 2020-12-08 Common Stock 10364.0000 0.0000 D Option (Right to Buy) 84.5750 2014-02-04 4 M 0 11252.0000 0.0000 D 2021-12-14 Common Stock 11252.0000 11253.0000 D Represents the weighted average sales price for price increments ranging from $128 to $128.06. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $127 to $127.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 1.781 shares acquired under the Company's 401(k) Plan from December 10, 2013 to February 3, 2014. Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Options fully vested in accordance with schedule upon achievement of certain performance criteria. Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Of this original grant, 11,252 options are fully vested and the remaining 11,253 options will vest in two equal annual installments on 12/14/2014 and 12/14/2015. Myra McGinley, Attorney-in-Fact 2014-02-06